Realize the Current Situation of COPD Patients in China

Trial Identifier: D2287R00114
Sponsor: AstraZeneca
NCTID:: NCT03131362
Start Date: June 2017
Primary Completion Date: August 2020

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
China Beijing, China, 100029